Owkin
3 known investors
Owkin develops AI Scientist, an autonomous AI system that uses biological large language models and multimodal patient data to accelerate drug discovery for pharmaceutical and biotech companies. The company aims to automate early-stage R&D and compress decades of discovery timelines into years.
AI & Machine LearningBiotechDeep TechDigital Health
Founders & leadership
Co
Clinical oncologist and machine learning pioneer
Investors · 3
In the news
- Owkin Secures $33.0M Investment | Signalbasetrysignalbase.com · 2026
- Owkin spinout Waiv raises $33m to scale AI-powered medical testingsifted.eu · 2026
- Sell or Invest in Owkin Stock Pre-IPOnasdaqprivatemarket.com · 2024
- Owkin becomes ‘unicorn’ with $180m investment from Sanofi - Owkinowkin.com · 2021
- Owkin - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxntracxn.com · 2021
- Owkin Raises $25M to Enhance Medical Research Machine Learning and Collaboration – AlleyWatchalleywatch.com · 2020